Ipilimumab in patients with melanoma and brain metastases: an open-label, phase 2 trial.

Margolin K, Ernstoff MS, Hamid O, Lawrence D, McDermott D, Puzanov I, Wolchok JD, Clark JI, Sznol M, Logan TF, Richards J, Michener T, Balogh A, Heller KN, Hodi FS
Lancet Oncol. 2012 13 (5): 459-65

PMID: 22456429 · DOI:10.1016/S1470-2045(12)70090-6

MeSH Terms (14)

Adult Aged Antibodies, Monoclonal Antineoplastic Agents Brain Neoplasms Female Humans Ipilimumab Male Melanoma Middle Aged Prospective Studies Skin Neoplasms Treatment Outcome

Connections (1)

This publication is referenced by other Labnodes entities: